Europlasma: Results of the 2025 General Meeting

Europlasma held its Ordinary and Extraordinary General Meeting on September 23, 2025, in Pessac. Shareholders held 1,103,443,370 shares out of 3,754,505,424 shares in the capital, reaching a quorum of 100% thanks to the intervention of ad hoc representative AJILINK VIGREUX. This meeting approved thirteen of the fourteen resolutions on the agenda.

The decisions adopted include the accounts for the 2024 financial year, the renewal of directors' mandates, and the appointment of a co-auditor. However, the resolution on certain agreements was not approved. Voting details will soon be available online.